Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study (vol 12, 662865, 2021)
FRONTIERS IN ENDOCRINOLOGY（2022）
关键词
clinical trial, cortisol, Cushing syndrome, glucocorticoid, hypercortisolism, hyperglycemia, hypertension, relacorilant
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要